Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 12, 2011European ASTI study to evaluate new nitinol stent to treat carotid artery disease
Boston Scientific Corporation (NYSE: BSX) has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its...
-
Jul 5, 2011Boston Scientific's Galway Site in Ballybrit Commercializes Innovative Mustang™ PTA Balloon Catheter
Galway, Ireland (July 5, 2011) -- Boston Scientific’s Galway site in Ballybrit is manufacturing and distributing the Company’s recently launched Mustang™ Percutaneous Transluminal...
-
Jul 4, 2011Expanded Heredia plant to manufacture a broad line of medical devices
San José, (July 4, 2011) Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the expansion of its manufacturing facility in Heredia, Costa Rica. This initiative will...
-
Jun 30, 2011
Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of...
-
Jun 30, 2011Detachable coils for peripheral embolization offer precise placement and control in coiling procedures
Boston Scientific Corporation (NYSE: BSX) today announced the immediate U.S. and European launch of its Interlock™ – 35 Fibered IDC™ Occlusion...
-
Jun 27, 2011
Boston Scientific Corporation (NYSE: BSX) today welcomed approval by the U.S. House of Representatives of the America Invents Act of 2011. The...
-
Jun 20, 2011Low-profile, high-pressure balloon offers physicians exceptional performance in a single platform for peripheral angioplasty procedures
Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch...
-
Jun 16, 2011
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2011 Wells Fargo Securities Healthcare Conference on June 22 in Boston....
-
Jun 7, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S....
-
May 27, 2011Action affects products distributed in U.S. and its territories; Atlantis® SR Pro available immediately as a substitute
Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in...
-
May 25, 2011Boston Scientific becomes the first and only company to offer two distinct drug-eluting stents to treat small vessels
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its 2.25...
-
May 23, 2011New technology designed to improve lead anchoring for physicians to be introduced at INS World Congress
London, UK (May 23, 2011) – Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System,...
-
May 23, 2011New technology designed to improve lead anchoring for physicians to be introduced at INS World Congress
London, UK (May 23, 2011) – Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of the Clik™ Anchor for its Precision Plus™ Spinal Cord Stimulator (SCS) System,...
-
May 20, 201112-month clinical data demonstrate low adverse event rates for Boston Scientific's 2.25 mm PROMUS Element Platinum Chromium Stent
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PLATINUM Small Vessel study, demonstrating excellent...
-
May 18, 2011Results for Boston Scientific WATCHMAN device presented at EuroPCR
Boston Scientific Corporation (NYSE: BSX) today announced results from a clinical study evaluating the use of its WATCHMAN® Left Atrial...
-
May 16, 2011Five-year data from RISA Trial presented at ATS adds to clinical evidence showing long-term safety of Boston Scientific's Alair® Bronchial Thermoplasty System
Boston Scientific Corporation (NYSE: BSX) today announced long-term safety data from the Research in Severe Asthma (RISA) Trial, which...
-
May 11, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that a jury in the District Court for the District of Delaware found that Cordis Corporation...
-
May 11, 2011Patients receive first device-based treatment for severe asthma
Natick, MA (May 11, 2011) -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its Alair® Bronchial Thermoplasty System in Canada. Doctors at Institut universitaire de...
-
May 10, 2011Elliott to remain on Board as non-executive director
Boston Scientific Corporation (NYSE: BSX) today announced that Ray Elliott will retire as President and Chief Executive Officer on December 31, 2011....
-
May 10, 2011Company sponsors additional efforts to promote education and awareness of severe asthma
Boston Scientific Corporation (NYSE: BSX) today announced its donation to the Asthma and Allergy Foundation of America (AAFA) to support education...
-
May 9, 2011Innovative Fine Needle Aspiration technology expands diagnostic capabilities in pancreas and gastrointestinal tract
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle,...
-
May 6, 2011World's smallest and thinnest high-energy CRT-Ds and ICDs offer new features to optimize patient management
Boston Scientific Corporation (NYSE: BSX) today announced the launch and first implants of its ENERGEN™ and PUNCTUA™ cardiac resynchronization...
-
May 5, 2011
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of its ALTITUDE® Clinical Science program, which...
-
May 5, 2011
Boston Scientific Corporation (NYSE: BSX) today announced that it is offering a new warranty program in the U.S. that covers its cardiac...
-
May 4, 2011System used in 25,000 patient procedures at 600 facilities worldwide since 2007
Boston Scientific Corporation (NYSE: BSX) today announced several milestones in the adoption of its SpyGlass® Direct Visualization System since its...